| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Herzog BH et al. | Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. | 2013 | Nature | pmid:23995678 |
| Eisenhoffer GT et al. | Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. | 2012 | Nature | pmid:22504183 |
| Vu TM et al. | Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. | 2017 | Nature | pmid:29045386 |
| Olivera A and Spiegel S | Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. | 1993 | Nature | pmid:8413613 |
| Choi OH et al. | Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. | 1996 | Nature | pmid:8602265 |
| Ng CK et al. | Drought-induced guard cell signal transduction involves sphingosine-1-phosphate. | 2001 | Nature | pmid:11279499 |
| D'Angelo G et al. | Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. | 2007 | Nature | pmid:17687330 |
| Cuvillier O et al. | Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. | 1996 | Nature | pmid:8657285 |
| Martin R | Multiple sclerosis: closing in on an oral treatment. | 2010 | Nature | pmid:20237554 |
| Mendoza A et al. | Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. | 2017 | Nature | pmid:28538737 |
| Ishii M et al. | Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. | 2009 | Nature | pmid:19204730 |
| Malinow R et al. | Persistent protein kinase activity underlying long-term potentiation. | 1988 | Nature | pmid:2847049 |
| Premenko-Lanier M et al. | Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection. | 2008 | Nature | pmid:18704087 |
| Bevan MJ and Fink PJ | Immunology: Surprising side effects. | 2008 | Nature | pmid:18704076 |
| Alvarez SE et al. | Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. | 2010 | Nature | pmid:20577214 |
| Coursol S et al. | Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins. | 2003 | Nature | pmid:12789341 |
| Blaho VA et al. | HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. | 2015 | Nature | pmid:26053123 |
| Jang GJ et al. | C2-ceramide induces vasodilation in phenylephrine-induced pre-contracted rat thoracic aorta: role of RhoA/Rho-kinase and intracellular Ca2+ concentration. | 2005 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16231160 |
| Czyborra C et al. | Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. | 2006 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16521006 |
| Alemany R et al. | Regulation and functional roles of sphingosine kinases. | 2007 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:17242884 |
| Trifilieff A et al. | Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. | 2009 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:19636535 |
| Ryu SK et al. | Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. | 2006 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16521007 |
| Jongsma M et al. | Validation of a rapid, non-radioactive method to quantify internalisation of G-protein coupled receptors. | 2007 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:17497135 |
| Pexa A and Deussen A | Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). | 2005 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16200394 |
| Stuebe S et al. | Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene. | 2008 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:18046543 |
| Hemmings DG | Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. | 2006 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16570136 |
| Morales M | [Participation of the phosphatidylinositol-3-kinase/Akt/endothelial-nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling]. | 2002 | Nefrologia | pmid:12107910 |
| Böhler T et al. | FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors. | 2004 | Nephrol. Dial. Transplant. | pmid:14767029 |
| Kim MG et al. | CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. | 2011 | Nephrol. Dial. Transplant. | pmid:20702533 |
| Westhoff TH et al. | The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. | 2007 | Nephrol. Dial. Transplant. | pmid:17526535 |
| Hanafusa N et al. | Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. | 2002 | Nephrol. Dial. Transplant. | pmid:11917049 |
| Sun XJ et al. | Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis. | 2017 | Nephrol. Dial. Transplant. | pmid:28206609 |
| Hoitsma AJ et al. | FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. | 2011 | Nephrol. Dial. Transplant. | pmid:21911597 |
| Domhan S et al. | Immunosuppressive therapy and post-transplant malignancy. | 2009 | Nephrol. Dial. Transplant. | pmid:18978068 |
| Kunzendorf U et al. | FTY720--the first compound of a new promising class of immunosuppressive drugs. | 2004 | Nephrol. Dial. Transplant. | pmid:15199193 |
| Lee SY et al. | Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice. | 2011 | Nephrology (Carlton) | pmid:21272128 |
| Klatt J et al. | [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis]. | 2007 | Nervenarzt | pmid:17668161 |
| Haas J et al. | [Fingolimod compassionate use program: case study on the concept of a therapy option for multiple sclerosis prior to marketing approval]. | 2012 | Nervenarzt | pmid:23203160 |
| Aktas O et al. | [Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system]. | 2011 | Nervenarzt | pmid:20842337 |
| Winkelmann A et al. | [Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations]. | 2012 | Nervenarzt | pmid:21845450 |
| Estrada-Bernal A et al. | Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma. | 2012 | Neuro-oncology | pmid:22351749 |
| He X et al. | Deregulation of sphingolipid metabolism in Alzheimer's disease. | 2010 | Neurobiol. Aging | pmid:18547682 |
| Malaplate-Armand C et al. | Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. | 2006 | Neurobiol. Dis. | pmid:16626961 |
| Schueler UH et al. | Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. | 2003 | Neurobiol. Dis. | pmid:14678774 |
| Hindle SJ et al. | A saposin deficiency model in Drosophila: Lysosomal storage, progressive neurodegeneration and sensory physiological decline. | 2017 | Neurobiol. Dis. | pmid:27913291 |
| Colombaioni L et al. | Serum deprivation increases ceramide levels and induces apoptosis in undifferentiated HN9.10e cells. | 2002 | Neurochem. Int. | pmid:11792463 |
| Li R et al. | Specific phosphorylation of αA-crystallin is required for the αA-crystallin-induced protection of astrocytes against staurosporine and C2-ceramide toxicity. | 2012 | Neurochem. Int. | pmid:22414529 |
| Yang Y et al. | Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions. | 2016 | Neurochem. Int. | pmid:26921668 |
| Manev H and Cagnoli CM | Ceramide-mediated and isoquinolinesulfonamide-sensitive pathways of neuronal death: anything in common? | 1997 | Neurochem. Int. | pmid:9220452 |
| Molderings GJ et al. | S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands. | 2007 | Neurochem. Int. | pmid:17559976 |
| Pasquaré SJ and Giusto NM | Diacylglyceride lipase activity in rod outer segments depends on the illumination state of the retina. | 2008 | Neurochem. Int. | pmid:18926868 |
| López-González MA et al. | The production of free oxygen radicals and nitric oxide in the rat cochlea. | 1998 | Neurochem. Int. | pmid:9694043 |
| Rodriguez-Lafrasse C and Vanier MT | Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. | 1999 | Neurochem. Res. | pmid:9972865 |
| Jang S et al. | Cytochemical alterations in the rat retina by LPS administration. | 2007 | Neurochem. Res. | pmid:17160463 |
| Giussani P et al. | Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. | 2007 | Neurochem. Res. | pmid:17151916 |
| Heacock AM and Agranoff BW | Protein kinase inhibitors block neurite outgrowth from explants of goldfish retina. | 1997 | Neurochem. Res. | pmid:9342720 |
| Dasgupta S et al. | Maternal alcohol consumption increases sphingosine levels in the brains of progeny mice. | 2007 | Neurochem. Res. | pmid:17701351 |
| Taniwaki T et al. | Ceramide induces apoptosis to immature cerebellar granule cells in culture. | 1999 | Neurochem. Res. | pmid:10344598 |
| Podbielska M et al. | Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. | 2012 | Neurochem. Res. | pmid:22451227 |
| Pasquaré SJ et al. | Involvement of lysophosphatidic acid, sphingosine 1-phosphate and ceramide 1-phosphate in the metabolization of phosphatidic acid by lipid phosphate phosphatases in bovine rod outer segments. | 2008 | Neurochem. Res. | pmid:18288612 |
| Bieberich E | There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. | 2011 | Neurochem. Res. | pmid:21136155 |
| Yi H et al. | Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells. | 2011 | Neurochem. Res. | pmid:21674237 |
| Katsel P et al. | Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? | Neurochem. Res. | pmid:17342407 | |
| Larocca JN et al. | Induction of oligodendrocyte apoptosis by C2-ceramide. | 1997 | Neurochem. Res. | pmid:9130266 |
| Jang S et al. | Changes in iNOS, GFAP and NR1 expression in various brain regions and elevation of sphingosine-1-phosphate in serum after immobilized stress. | 2008 | Neurochem. Res. | pmid:17940874 |
| Saito M et al. | Gangliosides attenuate ethanol-induced apoptosis in rat cerebellar granule neurons. | 1999 | Neurochem. Res. | pmid:10485581 |
| Gassowska M et al. | Sphingosine kinases/sphingosine-1-phosphate and death Signalling in APP-transfected cells. | 2014 | Neurochem. Res. | pmid:24452756 |
| Bieberich E | It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation. | 2012 | Neurochem. Res. | pmid:22246226 |
| Jang S et al. | Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. | 2011 | Neurochem. Res. | pmid:21076868 |
| Maciejek Z et al. | Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report. | Neurol. Neurochir. Pol. | pmid:23650003 | |
| Hashiba Y et al. | Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries. | 2007 | Neurol. Res. | pmid:17806208 |
| La Mantia L et al. | Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia. | 2014 | Neurol. Sci. | pmid:24756193 |
| Gasperini C and Ruggieri S | New oral drugs for multiple sclerosis. | 2009 | Neurol. Sci. | pmid:19882371 |
| Crespo C et al. | Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis. | 2014 | Neurologia | pmid:24161412 |
| Atkinson D et al. | Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy. | 2017 | Neurology | pmid:28077491 |
| Verhoeven K et al. | SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I. | 2004 | Neurology | pmid:15037712 |
| Goldman MD and Naismith RT | Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits. | 2015 | Neurology | pmid:25636716 |
| Kappos L et al. | Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis. | 2015 | Neurology | pmid:25636714 |
| Kowarik MC et al. | Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. | 2011 | Neurology | pmid:21464424 |
| Issa NP and Hentati A | VZV encephalitis that developed in an immunized patient during fingolimod therapy. | 2015 | Neurology | pmid:25416038 |
| Hohlfeld R et al. | Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy. | 2011 | Neurology | pmid:21339488 |
| Antel J and Hohlfeld R | Modulation of sphingosine 1-phosphate signaling in neurologic disease. | 2011 | Neurology | pmid:21360856 |
| Nolan R et al. | Fingolimod treatment in multiple sclerosis leads to increased macular volume. | 2013 | Neurology | pmid:23223539 |
| Slavin AJ and Zamvil SS | FTY720 and central memory: out of sight, out of mind. | 2010 | Neurology | pmid:20610831 |
| Schwarz A et al. | Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis. | 2010 | Neurology | pmid:20548047 |
| Hla T and Brinkmann V | Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. | 2011 | Neurology | pmid:21339489 |
| Soliven B et al. | The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. | 2011 | Neurology | pmid:21339490 |
| Giovannoni G and Naismith RT | Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomes. | 2014 | Neurology | pmid:24610331 |
| Jokubaitis VG et al. | Fingolimod after natalizumab and the risk of short-term relapse. | 2014 | Neurology | pmid:24610329 |
| Pilz G et al. | Tumefactive MS lesions under fingolimod: a case report and literature review. | 2013 | Neurology | pmid:24097813 |
| Paul F and Bourdette D | Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences. | 2013 | Neurology | pmid:24097812 |
| Wattjes MP et al. | Author response. | 2013 | Neurology | pmid:24044116 |
| Schneider JS and DiStefano L | Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. | 1994 | Neurology | pmid:8164837 |
| McNamara PH et al. | Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. | 2013 | Neurology | pmid:23858414 |
| Pfender N et al. | Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis. | 2015 | Neurology | pmid:25957334 |
| Tully T et al. | Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod. | 2015 | Neurology | pmid:25878178 |
| Bielekova B and McDermott MP | Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis? | 2015 | Neurology | pmid:25809305 |
| Kuhle J et al. | Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis. | 2015 | Neurology | pmid:25809304 |
| Ricklin ME et al. | T-cell response against varicella-zoster virus in fingolimod-treated MS patients. | 2013 | Neurology | pmid:23700335 |
| Kappos L et al. | Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial. | 2015 | Neurology | pmid:25795646 |
sphingosine
sphingosine is a lipid of Sphingolipids (SP) class.
Cross Reference
